Header Logo

Annabelle Volgman

Concepts (367)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
24
2023
183
8.120
Why?
Cardiovascular Diseases
21
2023
401
5.680
Why?
Stroke
21
2023
293
4.630
Why?
Heart Failure
8
2023
204
2.660
Why?
Female
78
2023
16211
2.190
Why?
Aortic Valve Stenosis
4
2023
23
2.170
Why?
Transcatheter Aortic Valve Replacement
4
2023
27
2.150
Why?
Humans
103
2023
29361
2.100
Why?
Anticoagulants
7
2022
100
2.080
Why?
Myocardial Infarction
11
2023
172
1.930
Why?
Healthcare Disparities
6
2020
76
1.850
Why?
Coronary Artery Disease
8
2022
123
1.840
Why?
Risk Factors
31
2023
2446
1.800
Why?
Sex Factors
18
2022
496
1.730
Why?
Pregnancy Complications, Cardiovascular
6
2023
17
1.680
Why?
Hospital Mortality
8
2023
141
1.650
Why?
Cardiologists
2
2023
14
1.630
Why?
Exercise
7
2022
468
1.500
Why?
Cardiology
5
2022
72
1.480
Why?
Cognitive Dysfunction
5
2023
938
1.470
Why?
Risk Assessment
14
2022
678
1.420
Why?
Sex Characteristics
7
2023
132
1.380
Why?
Hospitalization
8
2021
317
1.340
Why?
Myocardial Ischemia
4
2022
50
1.320
Why?
Life Style
8
2020
211
1.320
Why?
Women's Health
4
2020
245
1.280
Why?
Primary Prevention
4
2022
38
1.250
Why?
Male
48
2023
15637
1.240
Why?
Cardiovascular System
3
2022
14
1.240
Why?
Acute Kidney Injury
3
2023
49
1.240
Why?
Aged
40
2022
9447
1.230
Why?
Quality of Life
8
2023
664
1.230
Why?
United States
27
2023
2332
1.180
Why?
Physicians, Women
3
2022
18
1.170
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
63
1.160
Why?
Catheter Ablation
3
2022
78
1.100
Why?
Pacemaker, Artificial
3
2023
48
1.090
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
26
1.040
Why?
Health Status Disparities
4
2019
70
1.030
Why?
Adrenergic beta-Antagonists
2
2020
42
1.030
Why?
Arrhythmias, Cardiac
6
2019
150
1.030
Why?
Defibrillators, Implantable
3
2021
30
0.990
Why?
Anti-Arrhythmia Agents
7
2022
104
0.960
Why?
Middle Aged
32
2022
9823
0.960
Why?
American Heart Association
4
2023
29
0.940
Why?
Ischemic Attack, Transient
2
2023
20
0.930
Why?
Terminal Care
1
2023
27
0.880
Why?
Echocardiography, Doppler, Color
2
2019
13
0.870
Why?
Myocarditis
1
2022
6
0.870
Why?
Premature Birth
1
2022
6
0.860
Why?
Heart Defects, Congenital
1
2023
30
0.860
Why?
Breast Neoplasms
3
2021
329
0.830
Why?
Pregnancy
9
2023
404
0.810
Why?
Coronavirus
1
2021
2
0.800
Why?
Electrocardiography
7
2015
209
0.790
Why?
Length of Stay
4
2020
317
0.780
Why?
Social Media
1
2021
27
0.750
Why?
Chest Pain
1
2020
24
0.750
Why?
Intersectoral Collaboration
1
2020
9
0.740
Why?
Endothelium
1
2020
12
0.740
Why?
Brain Ischemia
1
2021
71
0.730
Why?
Vascular Diseases
1
2020
48
0.710
Why?
Patient Care Management
2
2021
18
0.710
Why?
Takotsubo Cardiomyopathy
1
2019
12
0.710
Why?
Treatment Outcome
14
2023
3476
0.700
Why?
Cardiomyopathies
1
2019
29
0.700
Why?
Ambulatory Care Facilities
2
2022
37
0.700
Why?
Myxoma
1
2019
6
0.700
Why?
Heart Neoplasms
1
2019
13
0.690
Why?
Comorbidity
5
2021
497
0.680
Why?
Heart Diseases
1
2020
73
0.680
Why?
Heart Failure, Diastolic
1
2018
2
0.680
Why?
Age Factors
8
2021
845
0.670
Why?
Betacoronavirus
1
2020
75
0.670
Why?
Hypertension
7
2023
266
0.670
Why?
Women's Health Services
1
2018
12
0.670
Why?
Prevalence
6
2020
491
0.660
Why?
Heart Ventricles
1
2019
170
0.650
Why?
Culturally Competent Care
1
2018
9
0.650
Why?
Delivery of Health Care, Integrated
1
2018
26
0.650
Why?
Warfarin
3
2016
37
0.640
Why?
Emigrants and Immigrants
1
2018
20
0.640
Why?
Coronavirus Infections
1
2020
86
0.640
Why?
Pneumonia, Viral
1
2020
89
0.630
Why?
Antineoplastic Agents
1
2020
218
0.630
Why?
Atherosclerosis
1
2018
72
0.610
Why?
Lipoprotein(a)
1
2016
5
0.560
Why?
Prognosis
7
2021
840
0.560
Why?
Cognition
3
2020
1279
0.560
Why?
Dyslipidemias
1
2016
23
0.550
Why?
Electrodes
1
2015
16
0.530
Why?
Diabetes Mellitus
3
2022
137
0.520
Why?
Health Knowledge, Attitudes, Practice
2
2022
194
0.520
Why?
Secondary Prevention
3
2022
64
0.510
Why?
Cost of Illness
1
2015
54
0.510
Why?
Social Support
1
2016
185
0.510
Why?
Patient Readmission
3
2019
123
0.470
Why?
Adult
15
2023
8604
0.470
Why?
Electric Countershock
6
2020
29
0.470
Why?
Magnetic Resonance Imaging
1
2019
1220
0.470
Why?
Aspirin
2
2020
83
0.470
Why?
Aortic Valve
3
2023
22
0.470
Why?
Aged, 80 and over
9
2021
4851
0.460
Why?
Retrospective Studies
10
2022
3273
0.450
Why?
Non-ST Elevated Myocardial Infarction
3
2022
3
0.440
Why?
ST Elevation Myocardial Infarction
3
2022
10
0.440
Why?
Atrial Appendage
2
2022
45
0.410
Why?
Coronary Angiography
3
2020
91
0.410
Why?
Patient Acceptance of Health Care
1
2012
79
0.410
Why?
Alzheimer Disease
1
2023
1943
0.390
Why?
Frailty
2
2022
38
0.380
Why?
Cardiovascular Agents
2
2021
28
0.360
Why?
Cross-Sectional Studies
5
2022
965
0.360
Why?
Cardiac Resynchronization Therapy Devices
2
2019
8
0.360
Why?
Feasibility Studies
2
2020
227
0.350
Why?
Hospital Costs
2
2020
68
0.350
Why?
Biomarkers
4
2022
692
0.340
Why?
Practice Guidelines as Topic
3
2021
333
0.320
Why?
Ventricular Fibrillation
2
2021
30
0.310
Why?
Percutaneous Coronary Intervention
3
2022
23
0.310
Why?
Heart Atria
2
2019
74
0.310
Why?
Cohort Studies
5
2023
1939
0.280
Why?
Health Status
2
2018
227
0.270
Why?
Administration, Oral
3
2016
140
0.270
Why?
Randomized Controlled Trials as Topic
5
2020
340
0.270
Why?
Sex Distribution
3
2019
87
0.260
Why?
Societies, Medical
3
2023
190
0.260
Why?
Antihypertensive Agents
2
2020
85
0.250
Why?
Hemorrhage
5
2020
75
0.250
Why?
Palliative Care
2
2023
145
0.250
Why?
Risk Adjustment
2
2021
12
0.250
Why?
Obesity
4
2020
290
0.240
Why?
Incidence
4
2020
756
0.240
Why?
Logistic Models
3
2021
407
0.240
Why?
Hospital Charges
2
2020
17
0.240
Why?
Young Adult
3
2020
1935
0.240
Why?
Leadership
2
2022
96
0.230
Why?
Illinois
2
2021
241
0.230
Why?
Cardiotoxicity
2
2020
5
0.230
Why?
Minority Groups
1
2023
67
0.230
Why?
Pulmonary Veins
1
2023
23
0.230
Why?
Age Distribution
2
2020
94
0.230
Why?
Cost-Benefit Analysis
2
2022
144
0.230
Why?
Maternal Mortality
1
2023
4
0.230
Why?
Morbidity
2
2019
63
0.220
Why?
Health Promotion
2
2016
161
0.220
Why?
Death
1
2023
48
0.220
Why?
Out-of-Hospital Cardiac Arrest
1
2022
8
0.220
Why?
Philippines
1
2022
5
0.220
Why?
Pregnancy Outcome
1
2022
20
0.220
Why?
Pregnant Women
1
2022
12
0.220
Why?
Cesarean Section
1
2022
30
0.210
Why?
Attitude
1
2022
29
0.210
Why?
Adolescent
2
2020
2280
0.210
Why?
Polypharmacy
1
2022
10
0.210
Why?
Vitamin K
1
2022
8
0.210
Why?
Sotalol
1
2021
11
0.210
Why?
Venous Thromboembolism
1
2022
37
0.210
Why?
Coronary Circulation
2
2020
43
0.210
Why?
Cardiac Electrophysiology
1
2021
3
0.210
Why?
Prospective Studies
3
2023
1812
0.210
Why?
Pandemics
2
2023
236
0.210
Why?
Troponin
1
2021
7
0.200
Why?
Shock, Cardiogenic
1
2021
10
0.200
Why?
Sexism
1
2021
8
0.200
Why?
Diagnostic Techniques, Cardiovascular
1
2021
2
0.200
Why?
Telemedicine
1
2023
99
0.200
Why?
Water-Electrolyte Imbalance
1
2021
2
0.200
Why?
Hormones
1
2021
13
0.200
Why?
Sleep Apnea, Obstructive
1
2022
52
0.200
Why?
Death, Sudden, Cardiac
1
2021
20
0.200
Why?
Overweight
1
2022
65
0.200
Why?
Alcohol Drinking
1
2022
78
0.200
Why?
Women's Rights
1
2021
2
0.200
Why?
Weight Loss
1
2022
98
0.200
Why?
National Institutes of Health (U.S.)
1
2021
30
0.200
Why?
Angioplasty
1
2020
5
0.200
Why?
Signal Processing, Computer-Assisted
2
1998
38
0.190
Why?
Peripheral Arterial Disease
1
2020
10
0.190
Why?
Physician-Patient Relations
1
2021
39
0.190
Why?
Health Expenditures
1
2020
19
0.190
Why?
Career Choice
1
2021
30
0.190
Why?
Hyperlipidemias
1
2020
18
0.190
Why?
Heart Valve Diseases
1
2020
22
0.190
Why?
Disease Outbreaks
1
2021
88
0.190
Why?
Postoperative Hemorrhage
1
2020
24
0.190
Why?
Periodicals as Topic
1
2021
41
0.190
Why?
Endovascular Procedures
1
2020
33
0.190
Why?
Myocardial Revascularization
1
2020
18
0.190
Why?
Postnatal Care
1
2020
7
0.190
Why?
Accidental Falls
1
2022
116
0.190
Why?
Delivery, Obstetric
1
2020
14
0.190
Why?
Heart Valve Prosthesis Implantation
1
2020
22
0.190
Why?
Radiation-Protective Agents
1
2020
3
0.180
Why?
Protective Factors
1
2020
17
0.180
Why?
Infant, Newborn
1
2022
604
0.180
Why?
Colchicine
1
2020
10
0.180
Why?
Social Class
1
2020
65
0.180
Why?
Prostatic Neoplasms
1
2021
106
0.180
Why?
Income
1
2020
75
0.180
Why?
Odds Ratio
2
2020
285
0.180
Why?
Thrombolytic Therapy
1
2020
56
0.180
Why?
After-Hours Care
1
2019
1
0.180
Why?
Radiation Injuries
1
2020
34
0.180
Why?
Global Health
1
2019
55
0.180
Why?
Up-Regulation
2
2021
174
0.180
Why?
Clinical Trials as Topic
1
2021
324
0.180
Why?
Health Behavior
1
2020
159
0.180
Why?
Multimodal Imaging
1
2019
20
0.170
Why?
Cardiac Resynchronization Therapy
1
2019
21
0.170
Why?
Heart
1
2019
91
0.170
Why?
Treatment Refusal
1
2018
13
0.170
Why?
Heart Transplantation
1
1998
38
0.170
Why?
Asia, Western
1
2018
2
0.160
Why?
Indian Ocean Islands
1
2018
2
0.160
Why?
Surveys and Questionnaires
3
2022
1184
0.160
Why?
Procainamide
1
1998
23
0.160
Why?
Intensive Care Units
1
2021
301
0.160
Why?
Walking
1
2020
252
0.160
Why?
Atrial Flutter
1
1998
20
0.160
Why?
Graft Rejection
1
1998
76
0.160
Why?
Reproducibility of Results
3
2017
788
0.160
Why?
Tachycardia
2
2021
48
0.160
Why?
Sulfonamides
1
1998
54
0.160
Why?
Diagnosis, Differential
1
2019
389
0.160
Why?
Memory Disorders
1
2019
174
0.160
Why?
Inpatients
1
2019
141
0.160
Why?
Coronary Disease
2
2020
86
0.150
Why?
Patient Discharge
1
2018
149
0.150
Why?
Diet Surveys
1
2017
19
0.150
Why?
Lupus Erythematosus, Systemic
1
2020
202
0.150
Why?
Nutrition Assessment
1
2017
31
0.150
Why?
Rivaroxaban
1
2016
8
0.150
Why?
Dabigatran
1
2016
7
0.150
Why?
Neoplasms
1
2020
247
0.150
Why?
Evidence-Based Medicine
1
2018
206
0.150
Why?
Pyridones
1
2016
13
0.150
Why?
Echocardiography
4
2023
171
0.150
Why?
Evidence-Based Practice
1
2017
77
0.150
Why?
Thiazoles
1
2016
35
0.150
Why?
Pyridines
1
2016
42
0.150
Why?
Patient Selection
2
2020
232
0.140
Why?
Dementia
1
2022
521
0.140
Why?
Coronary Vessels
2
2021
46
0.140
Why?
Georgia
1
2016
12
0.140
Why?
Sensitivity and Specificity
2
2015
553
0.140
Why?
Platelet Aggregation Inhibitors
1
2016
49
0.140
Why?
Pyrazoles
1
2016
44
0.140
Why?
Cholesterol, LDL
1
2016
30
0.140
Why?
Diet, Mediterranean
1
2017
62
0.140
Why?
Health Surveys
1
2016
96
0.140
Why?
Self Efficacy
1
2016
57
0.140
Why?
Chicago
2
2016
865
0.130
Why?
Miniaturization
1
2015
2
0.130
Why?
Preventive Health Services
1
2015
15
0.130
Why?
Equipment Design
2
2015
185
0.130
Why?
Heart Rate
2
2009
142
0.130
Why?
Equipment Failure Analysis
1
2015
106
0.130
Why?
Smoking
2
2018
194
0.120
Why?
Needs Assessment
1
2013
47
0.110
Why?
Cardiac Pacing, Artificial
2
1992
81
0.110
Why?
Drug Monitoring
1
2012
24
0.110
Why?
Heart Conduction System
1
1992
32
0.110
Why?
Activities of Daily Living
1
2016
502
0.110
Why?
Data Collection
1
2012
107
0.110
Why?
Registries
3
2022
189
0.100
Why?
Blood Pressure
2
2023
238
0.090
Why?
Motor Activity
1
2013
369
0.090
Why?
Coronary Artery Bypass
2
2020
32
0.090
Why?
Survival Rate
2
2019
349
0.080
Why?
Databases, Factual
2
2019
330
0.080
Why?
Azetidines
1
2006
2
0.070
Why?
Benzylamines
1
2006
11
0.070
Why?
Severity of Illness Index
2
2021
1113
0.070
Why?
Time Factors
3
2021
1618
0.070
Why?
Body Mass Index
2
2020
427
0.070
Why?
Endpoint Determination
1
2004
28
0.060
Why?
Blood Pressure Monitoring, Ambulatory
1
2023
5
0.060
Why?
Pharmacists
1
2023
16
0.060
Why?
Postoperative Complications
2
2020
957
0.060
Why?
Follow-Up Studies
2
2019
1829
0.060
Why?
Urokinase-Type Plasminogen Activator
1
2022
5
0.060
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
41
0.050
Why?
Double-Blind Method
2
2006
503
0.050
Why?
Flecainide
1
2021
14
0.050
Why?
Genetic Testing
1
2022
64
0.050
Why?
Microcirculation
1
2021
36
0.050
Why?
Ischemia
1
2021
27
0.050
Why?
Delivery of Health Care
1
2023
152
0.050
Why?
Peripartum Period
1
2021
3
0.050
Why?
Pregnancy, High-Risk
1
2021
3
0.050
Why?
Chlorides
1
2021
24
0.050
Why?
Diuretics
1
2021
15
0.050
Why?
Recurrence
2
2006
350
0.050
Why?
Health Services Research
1
2021
41
0.050
Why?
Sodium
1
2021
76
0.050
Why?
Hypercholesterolemia
1
2020
29
0.050
Why?
Vascular Endothelial Growth Factor A
1
2020
65
0.050
Why?
Patient Preference
1
2021
33
0.050
Why?
Fetal Growth Retardation
1
2020
2
0.050
Why?
Polycystic Ovary Syndrome
1
2020
3
0.050
Why?
Abortion, Spontaneous
1
2020
9
0.050
Why?
Education, Medical
1
2021
49
0.050
Why?
Menopause, Premature
1
2020
7
0.050
Why?
Lactation
1
2021
62
0.050
Why?
Case-Control Studies
2
2000
638
0.050
Why?
Sleep Apnea, Central
1
2000
25
0.050
Why?
Clinical Decision-Making
1
2020
36
0.050
Why?
Health Care Costs
1
2020
70
0.050
Why?
Attitude to Health
1
2020
97
0.050
Why?
Radiotherapy
1
2020
50
0.040
Why?
Curriculum
1
2021
155
0.040
Why?
Costs and Cost Analysis
1
2019
36
0.040
Why?
Autoimmune Diseases
1
2020
61
0.040
Why?
Thrombectomy
1
2019
27
0.040
Why?
Cause of Death
1
2019
65
0.040
Why?
Multivariate Analysis
1
2020
324
0.040
Why?
Disease Management
1
2020
114
0.040
Why?
Psychology
1
2018
20
0.040
Why?
Health Services Needs and Demand
1
2018
53
0.040
Why?
Heredity
1
2018
6
0.040
Why?
Cancer Survivors
1
2018
10
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
200
0.040
Why?
Diet, Western
1
2017
6
0.040
Why?
Quality Improvement
1
2018
158
0.040
Why?
Breast Feeding
1
2018
155
0.040
Why?
Body Composition
1
2016
56
0.030
Why?
Waist Circumference
1
2015
36
0.030
Why?
Risk
1
2016
217
0.030
Why?
Drug Therapy, Combination
1
2016
241
0.030
Why?
Body Weight
1
2016
133
0.030
Why?
Decision Making
1
2018
220
0.030
Why?
Genetic Predisposition to Disease
1
2018
441
0.030
Why?
Patient Compliance
1
2016
164
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
3
0.030
Why?
Dextroamphetamine
1
1993
6
0.030
Why?
Social Networking
1
2013
10
0.030
Why?
Syncope
1
1993
8
0.030
Why?
Hypotension, Orthostatic
1
1993
16
0.030
Why?
Efficiency
1
2013
15
0.030
Why?
Albuterol
1
1993
15
0.030
Why?
Bradycardia
1
1993
28
0.030
Why?
Interviews as Topic
1
2013
130
0.030
Why?
Program Evaluation
1
2013
132
0.030
Why?
Tachycardia, Ventricular
1
1992
34
0.030
Why?
Cardiac Catheterization
1
1992
88
0.030
Why?
Asthma
1
1993
138
0.020
Why?
Animals
1
2020
4577
0.020
Why?
Chemical and Drug Induced Liver Injury
1
2006
13
0.020
Why?
Estrogen Replacement Therapy
1
2006
20
0.020
Why?
Thromboembolism
1
2006
18
0.020
Why?
Chi-Square Distribution
1
2006
145
0.020
Why?
Proportional Hazards Models
1
2006
340
0.020
Why?
Combined Modality Therapy
1
2004
364
0.010
Why?
Electrocardiography, Ambulatory
1
2000
21
0.010
Why?
Bronchoscopy
1
2000
25
0.010
Why?
Tracheostomy
1
2000
19
0.010
Why?
Respiration
1
2000
35
0.010
Why?
Anesthesia
1
2000
34
0.010
Why?
Child
1
2000
1345
0.010
Why?
False Positive Reactions
1
1993
33
0.010
Why?
Administration, Inhalation
1
1993
25
0.010
Why?
Contraindications
1
1993
41
0.010
Why?
Posture
1
1993
78
0.010
Why?
Action Potentials
1
1993
137
0.010
Why?
ROC Curve
1
1992
138
0.010
Why?
Analysis of Variance
1
1992
321
0.010
Why?
Volgman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (367)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_